Results 81 to 90 of about 8,412,464 (305)

Pharmacological Therapy of Portal Hypertension [PDF]

open access: yes, 2017
Portal hypertension is a clinical syndrome characterized by pathological elevation of portal venous pressure and all its consequences. In portal hypertension, there is an increase in pressure in the veins that carry blood from the splanchnic organs to ...
Budi Widodo   +11 more
core   +1 more source

Digital Healthy Aging in China: Current Landscape and the Way Forward

open access: yesHealth Care Science, EarlyView.
This review illustrates China's journey toward digital healthy aging, navigating the challenges of population aging through national strategies and innovative digital technologies to enable integrated, personalized care for older adults. ABSTRACT China is experiencing rapid population aging, which poses increasing challenges for healthcare and social ...
Yingpeng Qiu   +4 more
wiley   +1 more source

Pathophysiology of Portal Hypertension [PDF]

open access: yesClinics in Liver Disease, 1964
Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. As portal hypertension develops, the formation of collateral vessels and arterial vasodilation progresses, which results in increased blood flow to the portal circulation.
openaire   +2 more sources

Noncirrhotic Portal Hypertension [PDF]

open access: yesJournal of Clinical and Experimental Hepatology, 2011
Portal hypertension is characterized by an increase in portal pressure (> 10 mmHg) and could be a result of cirrhosis of the liver or of noncirrhotic diseases. When portal hypertension occurs in the absence of liver cirrhosis, noncirrhotic portal hypertension (NCPH) must be considered. The prognosis of this disease is much better than that of cirrhosis.
Harshal, Rajekar   +3 more
openaire   +2 more sources

Portal Hypertension in Children

open access: yes, 2016
Portal hypertension is defined as an increase of blood pressure in the portal venous bed beyond the physiological values. In childhood it is usually caused by an increase of resistance to the blood flow from the mesenteric venous circulation through ...
Neil Di Salvo   +5 more
core   +1 more source

Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study

open access: yesBMC Gastroenterology
Purpose Hepatocellular carcinoma (HCC) has a poor prognosis, and alpha-fetoprotein (AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals cannot be disregarded.
Chengyu Liu   +12 more
doaj   +1 more source

Dual Portal Hypertension in Hepatic Tuberculosis: A Case Report

open access: yesGE: Portuguese Journal of Gastroenterology
Background: Hepatic tuberculosis in itself is a rare condition, and that causing portal hypertension is even rarer. We present a unique clinical scenario of portal hypertension in a 64-year-old woman, with tuberculosis causing both sinusoidal ...
Amal Joseph   +3 more
doaj   +1 more source

Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study

open access: yesPulmonary Circulation, 2020
Patients with portal hypertension may develop pulmonary hypertension. The economic implications of these comorbidities have not been systematically assessed. We compared healthcare resource utilization and costs in the United States between patients with
Sandeep Sahay   +4 more
doaj   +1 more source

Portal hypertensive biliopathy [PDF]

open access: yesGut, 2006
Extrahepatic portal venous obstruction (EHPVO) is a common cause of portal hypertension in the developing countries, and constitutes up to 40% of all patients with portal hypertension.1,2 EHPVO is a common cause of major upper-gastrointestinal bleeding among children.2–4 The most common presentation in children is well-tolerated variceal bleeding and ...
Radha K, Dhiman   +4 more
openaire   +2 more sources

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation

open access: yesLiver Transplantation, EarlyView., 2022
Abstract Hepatopulmonary syndrome (HPS) is associated with increased waitlist mortality in liver transplantation (LT) candidates. Children with HPS are granted Model for End‐Stage Liver Disease (MELD)/Pediatric End‐Stage Liver Disease (PELD) exception points for waitlist prioritization in the United States based on criterion developed for adults.
Muhammad H. Raza   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy